TNF and irritable bowel syndrome: When IBS-associated SNPs were tested as predictors for clinical endpoints including disease activity, number of visits, examinations, hospitalisation weeks, medical therapies and TNF-inhibitor usage, no significant association robust to Bonferroni or Benjamini–Hochberg correction could be identified (data not shown).